Chemokine receptor expression on B cells and effect of interferon-β in multiple sclerosis

Torben L. Sorensen*, Hanne Roed, Finn Sellebjerg

*Corresponding author af dette arbejde

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    We investigated the B-cell expression of chemokine receptors CXCR3, CXCR5 and CCR5 in the blood and cerebrospinal fluid (CSF) from patients in relapse of multiple sclerosis (MS) and in neurological controls. Chemokine receptor expression was also studied in interferon-β-treated patients with relapsing-remitting or secondary progressive MS. We observed significantly higher expression of CXCR3 on B cells in the CSF in active MS than in controls. Patients with active MS also had higher B-cell expression of CCR5 in blood. No major differences between RRMS and SPMS patients were detected, and chemokine receptor expression was not affected by interferon-β treatment.

    OriginalsprogEngelsk
    Sider (fra-til)125-131
    Antal sider7
    TidsskriftJournal of Neuroimmunology
    Vol/bind122
    Udgave nummer1-2
    DOI
    StatusUdgivet - 29 jan. 2002

    Fingeraftryk

    Udforsk hvilke forskningsemner 'Chemokine receptor expression on B cells and effect of interferon-β in multiple sclerosis' indeholder.

    Citationsformater